SMT201600215B - Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme - Google Patents

Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme

Info

Publication number
SMT201600215B
SMT201600215B SM201600215T SM201600215T SMT201600215B SM T201600215 B SMT201600215 B SM T201600215B SM 201600215 T SM201600215 T SM 201600215T SM 201600215 T SM201600215 T SM 201600215T SM T201600215 B SMT201600215 B SM T201600215B
Authority
SM
San Marino
Prior art keywords
same
sterol
derivatives
preparing
treatment
Prior art date
Application number
SM201600215T
Other languages
English (en)
Inventor
Ludovic Clarion
Marcel Mersel
Didier Petite
Original Assignee
Beta Innov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Innov filed Critical Beta Innov
Publication of SMT201600215B publication Critical patent/SMT201600215B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SM201600215T 2012-05-10 2016-07-05 Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme SMT201600215B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12305518.8A EP2662382B1 (fr) 2012-05-10 2012-05-10 Dérivés de stérol, leur procédé de préparation, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement du glioblastome multiple

Publications (1)

Publication Number Publication Date
SMT201600215B true SMT201600215B (it) 2016-08-31

Family

ID=46149353

Family Applications (2)

Application Number Title Priority Date Filing Date
SM20180147T SMT201800147T1 (it) 2012-05-10 2013-05-07 Derivati dello sterolo e loro uso per il trattamento di patologie che coinvolgono cellule astrocitiche trasformate o per il trattamento di emopatie maligne
SM201600215T SMT201600215B (it) 2012-05-10 2016-07-05 Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SM20180147T SMT201800147T1 (it) 2012-05-10 2013-05-07 Derivati dello sterolo e loro uso per il trattamento di patologie che coinvolgono cellule astrocitiche trasformate o per il trattamento di emopatie maligne

Country Status (23)

Country Link
US (1) US10800806B2 (it)
EP (2) EP2662382B1 (it)
JP (1) JP6270823B2 (it)
KR (1) KR102160316B1 (it)
CN (1) CN104302655B (it)
BR (1) BR112014026948B1 (it)
CA (1) CA2871714C (it)
CY (2) CY1117723T1 (it)
DK (2) DK2662382T3 (it)
ES (2) ES2580331T3 (it)
HR (2) HRP20180345T1 (it)
HU (2) HUE029243T2 (it)
IN (1) IN2014DN09437A (it)
LT (1) LT2847204T (it)
ME (1) ME02436B (it)
PL (2) PL2662382T3 (it)
PT (2) PT2662382T (it)
RS (2) RS54926B1 (it)
RU (1) RU2627710C2 (it)
SI (2) SI2662382T1 (it)
SM (2) SMT201800147T1 (it)
TR (1) TR201802700T4 (it)
WO (1) WO2013168096A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3013048A1 (fr) * 2013-11-12 2015-05-15 Beta Innov Derive de sterol, son procede de preparation, composition pharmaceutique le contenant et son utilisation pour le traitement du glioblastome multiforme
EP3593789A1 (fr) * 2018-07-11 2020-01-15 Beta Innov Composition contenant un dérivé de 7beta-hydroxycholestérol et un véhicule lipidique, et son utilisation dans le traitement de pathologies néoplasiques
WO2022245122A1 (ko) * 2021-05-18 2022-11-24 연세대학교 산학협력단 암의 예방, 개선 또는 치료용 조성물
KR102689231B1 (ko) * 2021-05-18 2024-07-30 연세대학교 산학협력단 암의 예방, 개선 또는 치료용 조성물
WO2024030660A2 (en) * 2022-08-04 2024-02-08 University Of Massachusetts Cholesterol-modified hyaluronic acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602100D0 (sv) 1996-05-30 1996-05-30 Magnus Axelson New pharmaceuticals
JP2006503840A (ja) * 2002-09-25 2006-02-02 フォーブス メディ−テック インコーポレーテッド ステロール及び/又はスタノール及び抗炎症剤の特定の種類を含有する新規構造体及び組成物、並びに、心血管疾患、その根底にある高脂血症を含む病気、及び原因又は症状の一部として炎症を有する他の障害の治療又は予防におけるそれらの使用

Also Published As

Publication number Publication date
EP2662382B1 (fr) 2016-04-06
PT2662382T (pt) 2016-07-13
IN2014DN09437A (it) 2015-07-17
KR20150013254A (ko) 2015-02-04
RS57065B1 (sr) 2018-06-29
EP2662382A1 (fr) 2013-11-13
CY1120395T1 (el) 2019-07-10
KR102160316B1 (ko) 2020-09-25
PL2847204T3 (pl) 2018-06-29
BR112014026948B1 (pt) 2022-05-24
RU2014149705A (ru) 2016-07-10
CY1117723T1 (el) 2017-05-17
DK2847204T3 (en) 2018-03-12
HRP20180345T1 (hr) 2018-06-01
ME02436B (me) 2016-09-20
PT2847204T (pt) 2018-03-21
BR112014026948A2 (pt) 2017-06-27
RS54926B1 (sr) 2016-10-31
EP2847204B1 (en) 2017-12-13
US20150086615A1 (en) 2015-03-26
HUE037004T2 (hu) 2018-08-28
SI2662382T1 (sl) 2016-08-31
PL2662382T3 (pl) 2016-10-31
DK2662382T3 (en) 2016-06-27
SMT201800147T1 (it) 2018-05-02
US10800806B2 (en) 2020-10-13
WO2013168096A1 (en) 2013-11-14
LT2847204T (lt) 2018-03-26
HUE029243T2 (en) 2017-02-28
JP6270823B2 (ja) 2018-01-31
CN104302655A (zh) 2015-01-21
JP2015520146A (ja) 2015-07-16
CA2871714A1 (en) 2013-11-14
SI2847204T1 (en) 2018-05-31
ES2580331T3 (es) 2016-08-23
TR201802700T4 (tr) 2018-03-21
EP2847204A1 (en) 2015-03-18
CA2871714C (en) 2022-09-20
HRP20160624T1 (hr) 2016-08-12
CN104302655B (zh) 2018-04-03
RU2627710C2 (ru) 2017-08-10
HK1207385A1 (en) 2016-01-29
HK1191654A1 (zh) 2014-08-01
ES2662123T3 (es) 2018-04-05

Similar Documents

Publication Publication Date Title
SMT201600144B (it) Nuovi derivati eterociclici e loro uso nel trattamento di disturbi neurologici
IL235923A0 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
IL240876B (en) History of aminopurine, their preparation and pharmaceutical preparations containing them
PL3444261T3 (pl) Pochodne 2,2-difluoropropionamidowe bardoksolonu metylu, ich kompozycje farmaceutyczne i formy polimorficzne do zastosowania w leczeniu określonych stanów
LT2807159T (lt) Nauji indolizino junginiai, jų gamybos būdai ir juos turinčios farmacinės kompozicijos, skirtos vėžio gydymui
IL237839A0 (en) History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them
IL238662A (en) Bandostatin derivatives, containing them and used to treat cancer
IL240496B (en) History of pyridine, process for their preparation, pharmaceutical preparations containing them and their use in medicine
IL235414A (en) The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
IL238060B (en) 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them
SI3069720T1 (sl) Farmacevtski sestavek, ki vsebuje derivate glutarimida, in njegova uporaba za zdravljenje eozinofilnih bolezni
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
ZA201505318B (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX339243B (es) Derivados fusionados sustituidos de imidazol, composiciones farmaceuticas y metodos de uso de los mismos.
HUP1300646A2 (en) Complexes of fulvestrant and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
SMT201600215B (it) Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme
IL244901A0 (en) Derivatives of aminotetralin and aminoindan, pharmaceutical compositions containing them and their use in therapy
IL243982A0 (en) History of piperidine urea, their preparation and pharmaceutical preparations containing them
IL246298B (en) History of piperidine, their preparation and pharmaceutical preparations containing them
IL246406A0 (en) History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them
IL243223B (en) History of imidazole, their preparation and pharmaceutical preparations containing them
IL239873A0 (en) The history of piperidinylcarbazole, their preparation and pharmaceutical preparations containing them
IL238826A (en) History of imidazole - piperidinyl, their preparation and their pharmaceutical preparations
SMT201700032B (it) Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeutiche
HUP1300393A2 (en) Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same